New York State Common Retirement Fund’s Albireo Pharma Inc ALBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,751
Closed -$254K 3248
2022
Q4
$254K Sell
11,751
-13
-0.1% -$275 ﹤0.01% 2623
2022
Q3
$228K Sell
11,764
-15,938
-58% -$330K ﹤0.01% 2718
2022
Q2
$550K Sell
27,702
-1,489
-5% -$39.3K ﹤0.01% 2320
2022
Q1
$871K Buy
29,191
+17,451
+149% +$511K ﹤0.01% 2176
2021
Q4
$273K Sell
11,740
-35
-0.3% -$931 ﹤0.01% 2756
2021
Q3
$367K Sell
11,775
-3,362
-22% -$104K ﹤0.01% 2635
2021
Q2
$533K Buy
15,137
+137
+0.9% +$4.45K ﹤0.01% 2567
2021
Q1
$529K Buy
15,000
+1,400
+10% +$51.7K ﹤0.01% 2423
2020
Q4
$510K Hold
13,600
﹤0.01% 2350
2020
Q3
$454K Hold
13,600
﹤0.01% 2259
2020
Q2
$360K Buy
13,600
+3,400
+33% +$80.2K ﹤0.01% 2381
2020
Q1
$167K Hold
10,200
﹤0.01% 2543
2019
Q4
$259K Hold
10,200
﹤0.01% 2615
2019
Q3
$204K Hold
10,200
﹤0.01% 2764
2019
Q2
$329K Hold
10,200
﹤0.01% 2574
2019
Q1
$329K Hold
10,200
﹤0.01% 2492
2018
Q4
$250K Hold
10,200
﹤0.01% 2614
2018
Q3
$336K Hold
10,200
﹤0.01% 2597
2018
Q2
$362K Buy
+10,200
New +$330K ﹤0.01% 2602

Other funds holding ALBO

New York State Common Retirement Fund's ALBO Position: Q1 2023 in Review

New York State Common Retirement Fund sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 11,751 shares — an estimated $254K sold.

New York State Common Retirement Fund first reported a position in ALBO in Q2 2018 and held it in 19 quarters. The position peaked at $871K in Q1 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • New York State Common Retirement Fund reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • New York State Common Retirement Fund sold 11,751 Albireo Pharma Inc shares in Q1 2023, an estimated $254K.
  • New York State Common Retirement Fund first reported a position in Albireo Pharma Inc in Q2 2018 and held it in 19 quarters.
  • New York State Common Retirement Fund's Albireo Pharma Inc position peaked at $871K in Q1 2022.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on New York State Common Retirement Fund's 13F filing for Q1 2023, filed 2 May 2023.